At the time of writing, Tarsus Pharmaceuticals Inc [TARS] stock is trading at $82.13, up 0.18%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The TARS shares have gain 4.92% over the last week, with a monthly amount glided 3.10%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tarsus Pharmaceuticals Inc [NASDAQ: TARS] stock has seen the most recent analyst activity on December 09, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $100. Previously, Mizuho started tracking the stock with Outperform rating on November 20, 2025, and set its price target to $100. Goldman initiated its recommendation with a Neutral and recommended $19 as its price target on November 20, 2023. William Blair started tracking with a Outperform rating for this stock on July 18, 2023, and assigned it a price target of $44. In a note dated May 18, 2023, Guggenheim initiated an Buy rating.
For the past year, the stock price of Tarsus Pharmaceuticals Inc fluctuated between $38.51 and $85.25. Currently, Wall Street analysts expect the stock to reach $84.75 within the next 12 months. Tarsus Pharmaceuticals Inc [NASDAQ: TARS] shares were valued at $82.13 at the most recent close of the market. An investor can expect a potential return of 3.19% based on the average TARS price forecast.
Analyzing the TARS fundamentals
According to Tarsus Pharmaceuticals Inc [NASDAQ:TARS], the company’s sales were 366.10M for trailing twelve months, which represents an 146.68% jump. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -0.24%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.15, Equity is -0.26 and Total Capital is -0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 80.82 points at the first support level, and at 79.51 for the second support level. However, for the 1st resistance point, the stock is sitting at 83.67, and for the 2nd resistance point, it is at 85.21.
Ratios To Look Out For
It is important to note that Tarsus Pharmaceuticals Inc [NASDAQ:TARS] has a current ratio of 4.29. As well, the Quick Ratio is 4.25, while the Cash Ratio is 0.96. Considering the valuation of this stock, the price to sales ratio is 9.52, the price to book ratio is 10.40.
Transactions by insiders
Recent insider trading involved Whitfield Dianne C., Chief Human Resources Officer, that happened on Dec 16 ’25 when 7397.0 shares were sold. Director, LINK WILLIAM J PHD completed a deal on Dec 15 ’25 to sell 12500.0 shares. Meanwhile, Director LINK WILLIAM J PHD sold 10446.0 shares on Dec 15 ’25.
